AAAAAA

   
Results: 1-8 |
Results: 8
BOOSTER IMMUNIZATION OF HIV-1 NEGATIVE VOLUNTEERS WITH HGP-30 VACCINEINDUCES PROTECTION AGAINST HIV-1 VIRUS CHALLENGE IN SCID MICE
Authors: SARIN PS TALMADGE JE HESELTINE P MURCAR N GENDELMAN HE COLEMAN R KELSEY L BECKNER S WINSHIP D KAHN J
Citation: Ps. Sarin et al., BOOSTER IMMUNIZATION OF HIV-1 NEGATIVE VOLUNTEERS WITH HGP-30 VACCINEINDUCES PROTECTION AGAINST HIV-1 VIRUS CHALLENGE IN SCID MICE, Vaccine, 17(1), 1999, pp. 64-71
CROSS-CLADE P17 PEPTIDE RECOGNITION BY ANTISERA TO HGP-30, A 30-AMINOACID SYNTHETIC PEPTIDE ANTIGEN FROM HIV TYPE-1 P17
Authors: ZIMMERMAN DH ULRICH JT WRIGHT C LLOYD JP WINSHIP MD SARIN PS
Citation: Dh. Zimmerman et al., CROSS-CLADE P17 PEPTIDE RECOGNITION BY ANTISERA TO HGP-30, A 30-AMINOACID SYNTHETIC PEPTIDE ANTIGEN FROM HIV TYPE-1 P17, AIDS research and human retroviruses, 14(9), 1998, pp. 741-749
ENZYME-LINKED-IMMUNOSORBENT-ASSAY QUANTIFICATION OF CYTOKINE CONCENTRATIONS IN HUMAN MENINGIOMAS
Authors: LEVY EI PAINO JE SARIN PS GOLDSTEIN AL CAPUTY AJ WRIGHT DC SEKHAR LN
Citation: Ei. Levy et al., ENZYME-LINKED-IMMUNOSORBENT-ASSAY QUANTIFICATION OF CYTOKINE CONCENTRATIONS IN HUMAN MENINGIOMAS, Neurosurgery, 39(4), 1996, pp. 823-828
TREATMENT OF AIDS WITH DRUGS TARGETED TO INHIBIT DIFFERENT STAGES OF THE HIV LIFE-CYCLE
Authors: SARIN PS GOLDSTEIN AL
Citation: Ps. Sarin et Al. Goldstein, TREATMENT OF AIDS WITH DRUGS TARGETED TO INHIBIT DIFFERENT STAGES OF THE HIV LIFE-CYCLE, Immunopharmacology and immunotoxicology, 17(2), 1995, pp. 217-245
HIV-1 P17 SYNTHETIC PEPTIDE VACCINE HGP-30 - INDUCTION OF IMMUNE-RESPONSE IN HUMAN-SUBJECTS AND PRELIMINARY EVIDENCE OF PROTECTION AGAINST HIV CHALLENGE IN SCID MICE
Authors: SARIN PS MORA CA NAYLOR PH MARKHAM R SCHWARTZ D KAHN J HESELTINE P GAZZARD B YOULE M RIOS A GOLDSTEIN AL
Citation: Ps. Sarin et al., HIV-1 P17 SYNTHETIC PEPTIDE VACCINE HGP-30 - INDUCTION OF IMMUNE-RESPONSE IN HUMAN-SUBJECTS AND PRELIMINARY EVIDENCE OF PROTECTION AGAINST HIV CHALLENGE IN SCID MICE, Cellular and molecular biology, 41(3), 1995, pp. 401-407
CD4-MODIFIED SYNTHETIC PEPTIDES CONTAINING PHENYLALANINE INHIBIT HIV-1 INFECTION IN-VITRO
Authors: LASARTE JJ SAROBE P GOLVANO J PRIETO I CIVEIRA MP GULLON A SARIN PS PRIETO J BORRASCUESTA F
Citation: Jj. Lasarte et al., CD4-MODIFIED SYNTHETIC PEPTIDES CONTAINING PHENYLALANINE INHIBIT HIV-1 INFECTION IN-VITRO, Journal of acquired immune deficiency syndromes, 7(2), 1994, pp. 129-134
EFFECTS OF CARRIER-PEPTIDE HAPTEN LINKAGE ON HUMORAL AND CELLULAR-RESPONSE - IMPLICATIONS FOR VACCINE DESIGN
Authors: KIRKLEY JE NAYLOR PH SARIN PS GOLDSTEIN AL
Citation: Je. Kirkley et al., EFFECTS OF CARRIER-PEPTIDE HAPTEN LINKAGE ON HUMORAL AND CELLULAR-RESPONSE - IMPLICATIONS FOR VACCINE DESIGN, The FASEB journal, 8(5), 1994, pp. 10000961-10000961
THYMOSIN-ALPHA-1 (T-ALPHA-1) DOES NOT STIMULATE THE GROWTH OF TUMOR-CELLS
Authors: NAYLOR PH CASLOW C SARIN PS SMITH M MUTCHNICK MG GOLDSTEIN AL
Citation: Ph. Naylor et al., THYMOSIN-ALPHA-1 (T-ALPHA-1) DOES NOT STIMULATE THE GROWTH OF TUMOR-CELLS, The Journal of immunology, 150(8), 1993, pp. 158-158
Risultati: 1-8 |